Technical Analysis for LABS - Medipharm Labs Corp.

Grade Last Price % Change Price Change
grade F 1.18 7.27% 0.080
LABS closed up 7.27 percent on Friday, July 10, 2020, on 31 percent of normal volume. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Down
Historical LABS trend table...

Date Alert Name Type % Chg
Bullish Engulfing Bullish 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish 7.27%
New 52 Week Low Weakness 7.27%
Wide Bands Range Expansion 7.27%
Down 3 Days in a Row Weakness 7.27%
Down 4 Days in a Row Weakness 7.27%
Down 5 Days in a Row Weakness 7.27%
Oversold Stochastic Weakness 7.27%

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


MediPharm Labs, through its subsidiary, is a pioneer in the cannabis industry and has the distinction of being the first company in Canada to become a licensed producer for cannabis oil production under the Access to Cannabis for Medical Purposes Regulations (ACMPR) without first receiving a cannabis cultivation licence. This expert focus on cannabis concentrates from our cGMP (current Good Manufacturing Practices) and ISO standard clean rooms and critical environments laboratory, allows MediPharm Labs to work with its established, Health Canada-approved cultivation partners to produce pharmaceutical-grade cannabis oil with a competitive advantage. MediPharm Labs is research-driven and focused on downstream secondary extraction methodology, distillation, and cannabinoid isolation and purification. MediPharm Labs, through its subsidiary, provides B2B contract processing of cannabis to Canadian authorized licensed producers and appropriate international growers, supplying integrity-assured cannabis oil to qualified companies for sale under their own brand. In addition, MediPharm Labs will supply raw materials, formulations, processing and packaging for the creation of ready-to-sell advanced derivative products. Through its subsidiary, MediPharm Labs Australia Pty. Ltd., MediPharm Labs has also completed its application process with the federal Office of Drug Control to extract and import medical cannabis products in Australia.
Medicine Cannabis Entheogens Euphoriants Medicinal Plants Herbalism Medical Cannabis Cannabis In Canada Legality Of Cannabis Health Sciences Pharmaceuticals Policy Access To Cannabis For Medical Purposes Regulations Business To Business Licensed Producer Licensed Producers Medical Cannabis Products

Is LABS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 7.28
52 Week Low 1.07
Average Volume 862,743
200-Day Moving Average 2.834
50-Day Moving Average 1.648
20-Day Moving Average 1.352
10-Day Moving Average 1.189
Average True Range 0.112
ADX 30.3
+DI 15.773
-DI 33.088
Chandelier Exit (Long, 3 ATRs ) 1.615
Chandelier Exit (Short, 3 ATRs ) 1.405
Upper Bollinger Band 1.782
Lower Bollinger Band 0.921
Percent B (%b) 0.3
BandWidth 63.663
MACD Line -0.158
MACD Signal Line -0.153
MACD Histogram -0.0051
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 1.345
Resistance 3 (R3) 1.330 1.260 1.318
Resistance 2 (R2) 1.260 1.218 1.268 1.308
Resistance 1 (R1) 1.220 1.192 1.240 1.235 1.299
Pivot Point 1.150 1.150 1.160 1.158 1.150
Support 1 (S1) 1.110 1.108 1.130 1.125 1.061
Support 2 (S2) 1.040 1.082 1.048 1.052
Support 3 (S3) 1.000 1.040 1.043
Support 4 (S4) 1.015